Skip to main content
. 2006 Jan;44(1):160–165. doi: 10.1128/JCM.44.1.160-165.2006

TABLE 4.

Clinical features of viridans streptococcal bacteremia in cancer patients

Feature No. of patients
S. mitis, n = 25 Non-S. mitis, n = 25 Both, n = 50 (%) P valueb
Women/men 10/15 11/14 21/29 NS
Age <18 yrs 5 0 5 (10.0) 0.018
Hematologic cancers 21 16 37 (74.0) NS
Anticancer treatment 21 20 41 (82.0) NS
Mucosal/GIa toxicity 17 14 31 (62.0) NS
Prior use of quinolone 20 16 36 (72.0) NS
Use of corticosteroids 6 8 14 (28.0) NS
ANC <500 for >10 days 18 9 27 (54.0) 0.011
ANC <100 10 3 13 (26.0) 0.024
Fever 25 21 46 (92.0) NS
Septic shock 13 4 17 (34.0) 0.007
Cause of death 1 0 1 (2.0) NS
a

GI, gastrointestinal.

b

By t test. NS, nonsignificant.